The EU will announce the results of the AstraZeneca vaccine evaluation WHO: The benefits of vaccination exceed the risks
China News Service, April 7th. According to comprehensive foreign media reports, due to reports of rare cases of cerebral thrombosis after vaccination with AstraZeneca in many European countries, there has been controversy over the safety of the vaccine. The European Medicines Agency will release the latest review results of the vaccine on the 7th or 8th. At the same time, a World Health Organization official said on the 6th that there is no evidence for the WHO to change its position that the benefits of AstraZeneca vaccine still outweigh the risks.
According to reports, Rogerio Gaspar, director of WHO’s Supervision and Prequalification Department, said that there has been no association between this vaccine and rare blood clots. He said that so far there is no evidence that the benefits and risk assessment results of AstraZeneca vaccine need to be changed.
Gasper expects that when the WHO Global Advisory Committee on Vaccine Safety meets, experts will make an updated assessment of the AstraZeneca vaccine.
p > On December 27, local time, many member states of the European Union officially launched the new crown vaccination work. The picture shows a medical staff in Italy doing the new crown vaccination work.
However, on the same day, Cavalieri, a senior official in charge of the vaccination strategy of the European Medicines Agency (EMA), said, “In my opinion, we can say that it is obvious that (cerebral thrombosis) It is related to the vaccine. However, we still don’t know what caused this reaction.”
However, EMA subsequently stated in a statement that its review of the vaccine is underway and expected The results of the review will be announced on the 7th or 8th. An AstraZeneca spokesperson declined to comment on the matter.